Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Canagliflozin in Asian patients with T2DM on metformin +/- SU
NCT01381900Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Aug 2011
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of canagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Janssen Pharmaceutical. Started Aug 2011; status: completed.
02
Drugs
canagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01381900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01381900.